COMP <GO>
SBRA vs BAC // ENTERPRISE SCALE & MARKET CAP
Sabra Health Care REIT Inc. (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: SBRA 6
— BAC 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BAC
LAST: $20.35 (+3.20%) • MKT CAP: $5.04B
market-cap
$5.04B
LAST: $49.66 (+0.18%) • MKT CAP: $342.04B
market-cap
$342.04B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBRA VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SBRA | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.50% | 2.50% | +3.00 | SBRA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.96% | 2.10% | +4.86 | SBRA | /fcf-yield <GO> |
| Operating Margin | — | 32.90% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 43.60% | 27.00% | +16.60 | SBRA | /net-margins <GO> |
| Revenue Growth (YoY) | 25.40% | 6.80% | +18.60 | SBRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.78% | 0.00% | +5.78 | SBRA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | BAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.3 | 30.8 | +22.50 | SBRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 10.9x | +16.10 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.04B | $342.04B | -$337.01B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SBRA REV | BAC REV | SBRA GROSS % | BAC GROSS % | SBRA FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $356.9M | $113.10B | — | — | $348.6M | $7.52B |
| FY 2024 | $284.6M | $105.86B | — | — | $310.5M | -$13.57B |
| FY 2023 | $236.2M | $102.77B | — | — | $300.6M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBRA // BETA —
BAC // BETA 0.90